Literature DB >> 21327155

Transcriptional regulation underlying recovery from a DNA damage-induced arrest.

Mónica Alvarez-Fernández1, René H Medema, Arne Lindqvist.   

Abstract

When the DNA of a cell is damaged, cell cycle progression is arrested and cell cycle-specific transcription is inhibited. However, cell cycle-specific transcription is required for eventual recovery from the DNA damage-induced arrest. Here we discuss recent findings that demonstrate how transcription is fine-tuned during the DNA damage response and how this controls the capacity to recover from a DNA damage arrest in G(2) phase.

Entities:  

Keywords:  DNA damage; FoxM1; G2/M; Wip1; checkpoint recovery; mitotic entry; recovery competence

Mesh:

Year:  2010        PMID: 21327155      PMCID: PMC3035183          DOI: 10.4161/trns.1.1.12063

Source DB:  PubMed          Journal:  Transcription        ISSN: 2154-1272


  23 in total

1.  Activation of Cdh1-dependent APC is required for G1 cell cycle arrest and DNA damage-induced G2 checkpoint in vertebrate cells.

Authors:  T Sudo; Y Ota; S Kotani; M Nakao; Y Takami; S Takeda; H Saya
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

Review 2.  Cell-cycle checkpoints and cancer.

Authors:  Michael B Kastan; Jiri Bartek
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

3.  FoxM1 is required for execution of the mitotic programme and chromosome stability.

Authors:  Jamila Laoukili; Matthijs R H Kooistra; Alexandra Brás; Jos Kauw; Ron M Kerkhoven; Ashby Morrison; Hans Clevers; René H Medema
Journal:  Nat Cell Biol       Date:  2005-01-16       Impact factor: 28.824

4.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

Authors:  F Bunz; A Dutriaux; C Lengauer; T Waldman; S Zhou; J P Brown; J M Sedivy; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

5.  Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex.

Authors:  C Lukas; C S Sørensen; E Kramer; E Santoni-Rugiu; C Lindeneg; J M Peters; J Bartek; J Lukas
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

Review 6.  Regulation of the G2/M transition by p53.

Authors:  W R Taylor; G R Stark
Journal:  Oncogene       Date:  2001-04-05       Impact factor: 9.867

7.  Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements.

Authors:  K S Katula; K L Wright; H Paul; D R Surman; F J Nuckolls; J W Smith; J P Ting; J Yates; J P Cogswell
Journal:  Cell Growth Differ       Date:  1997-07

8.  Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study.

Authors:  R Lev Bar-Or; R Maya; L A Segel; U Alon; A J Levine; M Oren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

9.  The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.

Authors:  M K Saville; R J Watson
Journal:  Oncogene       Date:  1998-11-26       Impact factor: 9.867

10.  Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions.

Authors:  Hee-Don Chae; Jeanho Yun; Yung-Jue Bang; Deug Y Shin
Journal:  Oncogene       Date:  2004-05-20       Impact factor: 9.867

View more
  2 in total

1.  Residual Cdk1/2 activity after DNA damage promotes senescence.

Authors:  Erik Müllers; Helena Silva Cascales; Kamila Burdova; Libor Macurek; Arne Lindqvist
Journal:  Aging Cell       Date:  2017-03-26       Impact factor: 9.304

2.  Fanconi anemia cells with unrepaired DNA damage activate components of the checkpoint recovery process.

Authors:  Alfredo Rodríguez; Leda Torres; Ulises Juárez; David Sosa; Eugenio Azpeitia; Benilde García-de Teresa; Edith Cortés; Rocío Ortíz; Ana M Salazar; Patricia Ostrosky-Wegman; Luis Mendoza; Sara Frías
Journal:  Theor Biol Med Model       Date:  2015-09-18       Impact factor: 2.432

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.